OneMedNet Corp
corporate_fare Company Profile
OneMedNet Corp (NASDAQ:ONMD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 30 items for ONMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-18, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 15 rated 8 or above. Recent SEC coverage for ONMD spans 4, 424B3, DEF 14A, 10-Q.
Recent high-impact activity:
- OneMedNet Bookings Surge 16X to $16.2M as Fulfillment Speed Jumps 50X
- CMO Jeffrey Yu Adds $90K in OneMedNet Stock at $0.63
- Prospectus Supplement Reveals Terms of New $25M Equity Line and $1M Insider Purchase
- Prospectus Supplement Reveals $25M Equity Line and Nasdaq Delisting Notice
- OneMedNet Sets September 18 Vote on Reverse Split and Equity Plan Expansion
Financial Snapshot
Dilution Risk
Moderate riskFiling-implied dilution signals for ONMD, detected from its recent SEC filings · based on capital-structure filings through 2026-08-20.
Going Concern Warning Issued · Nasdaq Delisting Threat
⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →